Bioventus Inc.

NASDAQ: BVS · Real-Time Price · USD
7.36
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.14%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bioventus Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
41.58M 36.96M 30.19M 43.93M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 2.64M 29.29M
Other Long-Term Assets
1.89M 3.14M 405.98M 50M
Receivables
127.39M 123.05M 136.56M 125.05M
Inventory
92.47M 91.33M 84.77M 61.69M
Other Current Assets
14.16M n/a 16.89M 20.28M
Total Current Assets
275.61M 268M 272.57M 263.1M
Property-Plant & Equipment
33.52M 49.96M 44.15M 40.17M
Goodwill & Intangibles
412.19M 489.81M 647.31M 842.82M
Total Long-Term Assets
452.35M 542.91M 1.1B 962.76M
Total Assets
727.96M 810.91M 1.37B 1.23B
Account Payables
23.69M 23.04M 36.7M 16.91M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
27.34M 27.85M 33.06M 18.04M
Other Current Liabilities
155.5M 69.16M 196.49M 76.14M
Total Current Liabilities
210.4M 175.5M 304.02M 180.86M
Long-Term Debt
308.29M 367M 385.01M 339.64M
Other Long-Term Liabilities
23.1M 46.08M 269.15M 23.01M
Total Long-Term Liabilities
331.95M 414.3M 656.41M 511.21M
Total Liabilities
542.35M 589.79M 960.43M 692.07M
Total Debt
335.63M 394.85M 418.07M 357.68M
Common Stock
82K 79K 78K 75K
Retained Earnings
-355.08M -321.54M -165.31M -6.6M
Comprehensive Income
-2.57M 794K -110K 179K
Shareholders Equity
147.94M 173.59M 325.24M 458.92M
Total Investments
n/a -1.21M 2.64M 29.29M